Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 116

1.

MicroRNA-139 is a predictor of prostate cancer recurrence and inhibits growth and migration of prostate cancer cells through cell cycle arrest and targeting IGF1R and AXL.

Nam RK, Benatar T, Wallis CJD, Kobylecky E, Amemiya Y, Sherman C, Seth A.

Prostate. 2019 Jul 3. doi: 10.1002/pros.23871. [Epub ahead of print]

PMID:
31269290
2.

Cancer diagnosis and risk of suicide after accounting for prediagnosis psychiatric care: A matched-cohort study of patients with incident solid-organ malignancies.

Klaassen Z, Wallis CJD, Chandrasekar T, Goldberg H, Sayyid RK, Williams SB, Moses KA, Terris MK, Nam RK, Urbach D, Austin PC, Kurdyak P, Kulkarni GS.

Cancer. 2019 Apr 25. doi: 10.1002/cncr.32146. [Epub ahead of print]

PMID:
31021430
3.

Re: Evaluation of Cancer Specific Mortality with Surgery versus Radiation as Primary Therapy for Localized High Grade Prostate Cancer in Men Younger than 60 Years.

Nam RK.

Eur Urol. 2019 Jul;76(1):129-130. doi: 10.1016/j.eururo.2019.03.003. Epub 2019 Mar 14. No abstract available.

PMID:
30879792
4.

The impact of psychiatric utilisation prior to cancer diagnosis on survival of solid organ malignancies.

Klaassen Z, Wallis CJD, Goldberg H, Chandrasekar T, Sayyid RK, Williams SB, Moses KA, Terris MK, Nam RK, Urbach D, Austin PC, Kurdyak P, Kulkarni GS.

Br J Cancer. 2019 Apr;120(8):840-847. doi: 10.1038/s41416-019-0390-0. Epub 2019 Mar 6.

PMID:
30837680
5.

Pelvic Complications After Prostate Cancer Radiation Therapy and Their Management: An International Collaborative Narrative Review.

Matta R, Chapple CR, Fisch M, Heidenreich A, Herschorn S, Kodama RT, Koontz BF, Murphy DG, Nguyen PL, Nam RK.

Eur Urol. 2019 Mar;75(3):464-476. doi: 10.1016/j.eururo.2018.12.003. Epub 2018 Dec 17. Review.

PMID:
30573316
6.

The cost of treatment and its related complications for men who receive surgery or radiation therapy for prostate cancer.

Garbens A, Wallis CJD, Matta R, Kodama R, Herschorn S, Narod S, Nam RK.

Can Urol Assoc J. 2018 Dec 3. doi: 10.5489/cuaj.5598. [Epub ahead of print]

PMID:
30526806
7.

Three-Dimensional Deformation and Wear of Internal Implant-Abutment Connection: A Comparative Biomechanical Study Using Titanium and Zirconia.

Nam RK, Lee SJ, Park EJ, Kwon HB, Yoon HI.

Int J Oral Maxillofac Implants. 2018 Nov/Dec;33(6):1279-1286. doi: 10.11607/jomi.6349.

PMID:
30427958
8.

Comparing Adjuvant vs Early-Salvage Radiotherapy After Radical Prostatectomy.

Chandrasekar T, Narod SA, Nam RK.

JAMA Oncol. 2018 Nov 1;4(11):1620. doi: 10.1001/jamaoncol.2018.3539. No abstract available.

PMID:
30422247
9.

Survival and peri-operative outcomes among patients with rectal cancer: the role of prior radiotherapy due to prostate cancer.

Feinberg AE, Wallis CJD, Nam RK, Hameed U.

Int J Colorectal Dis. 2019 Jan;34(1):97-104. doi: 10.1007/s00384-018-3175-7. Epub 2018 Oct 16.

PMID:
30327874
10.

Variation and Trends in Antidepressant Prescribing for Men Undergoing Treatment for Nonmetastatic Prostate Cancer: A Population-based Cohort Study.

Matta R, Wallis CJD, Goldenberg MG, Hird AE, Klaassen Z, Kulkarni G, Kodama RT, Herschorn S, Nam RK.

Eur Urol. 2019 Jan;75(1):3-7. doi: 10.1016/j.eururo.2018.08.035. Epub 2018 Sep 18.

PMID:
30241972
11.

Identification of a Novel MicroRNA Panel Associated with Metastasis Following Radical Prostatectomy for Prostate Cancer.

Nam RK, Wallis CJD, Amemiya Y, Benatar T, Seth A.

Anticancer Res. 2018 Sep;38(9):5027-5034. doi: 10.21873/anticanres.12821.

PMID:
30194146
12.

Evaluating the accuracy of multicomponent T2 parameters for luminal water imaging of the prostate with acceleration using inner-volume 3D GRASE.

Chan RW, Lau AZ, Detzler G, Thayalasuthan V, Nam RK, Haider MA.

Magn Reson Med. 2019 Jan;81(1):466-476. doi: 10.1002/mrm.27372. Epub 2018 Jul 29.

PMID:
30058296
13.

RE: Germline Mutations in the Kallikrein 6 Region and Predisposition for Aggressive Prostate Cancer.

Wallis CJD, Akbari MR, Narod SA, Nam RK.

J Natl Cancer Inst. 2017 Dec 1;109(12). doi: 10.1093/jnci/djx105. No abstract available.

PMID:
30053076
14.

MicroRNA-652 induces NED in LNCaP and EMT in PC3 prostate cancer cells.

Nam RK, Benatar T, Amemiya Y, Wallis CJD, Romero JM, Tsagaris M, Sherman C, Sugar L, Seth A.

Oncotarget. 2018 Apr 10;9(27):19159-19176. doi: 10.18632/oncotarget.24937. eCollection 2018 Apr 10.

15.

A Population-Based Assessment of Urologic Procedures and Operations After Surgery or Pelvic Radiation for Cervical Cancer.

Welk B, Wallis C, D'Souza D, McGee J, Nam RK.

Int J Gynecol Cancer. 2018 Jun;28(5):989-995. doi: 10.1097/IGC.0000000000001266.

PMID:
29664839
16.

The effect of selection and referral biases for the treatment of localised prostate cancer with surgery or radiation.

Wallis CJD, Morton G, Herschorn S, Kodama RT, Kulkarni GS, Appu S, Shayegan B, Buckley R, Grabowski A, Narod SA, Nam RK.

Br J Cancer. 2018 May;118(10):1399-1405. doi: 10.1038/s41416-018-0071-4. Epub 2018 Mar 29.

17.

Null association between androgen-deprivation therapy and nonprostate cancer mortality among older men with nonmetastatic prostate cancer.

Wallis CJD, Satkunasivam R, Herschorn S, Law C, Seth A, Kodama RT, Kulkarni GS, Nam RK.

Urol Oncol. 2018 May;36(5):241.e1-241.e6. doi: 10.1016/j.urolonc.2018.02.001. Epub 2018 Mar 2.

PMID:
29503141
18.

Next-generation prostate cancer risk calculator for primary care physicians.

Nam RK, Satkunavisam R, Chin JL, Izawa J, Trachtenberg J, Rendon R, Bell D, Singal R, Sherman C, Sugar L, Chagin K, Kattan MW.

Can Urol Assoc J. 2018 Feb;12(2):E64-E70. doi: 10.5489/cuaj.4696. Epub 2017 Dec 1.

19.

Association Between Primary Local Treatment and Non-prostate Cancer Mortality in Men With Nonmetastatic Prostate Cancer.

Wallis CJD, Satkunasivam R, Herschorn S, Law C, Seth A, Kodama RT, Kulkarni GS, Nam RK.

Urology. 2018 Apr;114:147-154. doi: 10.1016/j.urology.2017.12.013. Epub 2018 Jan 2.

PMID:
29305198
20.

Reply.

Wallis CJD, Nam RK.

Urology. 2018 Mar;113:145. doi: 10.1016/j.urology.2017.08.069. Epub 2017 Dec 27. No abstract available.

PMID:
29289357
21.

Population-based Analysis of Treatment Toxicity Among Men With Castration-resistant Prostate Cancer: A Phase IV Study.

Wallis CJD, Satkunasivam R, Saskin R, Bansal S, Kulkarni GS, Emmenegger U, Nam RK.

Urology. 2018 Mar;113:138-145. doi: 10.1016/j.urology.2017.08.067. Epub 2017 Nov 27.

22.

Peripheral Nerve Injury during Abdominal-Pelvic Surgery: Analysis of the National Surgical Quality Improvement Program Database.

Wallis CJD, Peltz S, Byrne J, Kroft J, Karanicolas P, Coburn N, Nathens AB, Nam RK, Hallet J, Satkunasivam R.

Am Surg. 2017 Nov 1;83(11):1214-1219.

PMID:
29183522
23.

Platelet to white blood cell ratio predicts 30-day postoperative infectious complications in patients undergoing radical nephrectomy for renal malignancy.

Garbens A, Wallis CJD, Bjarnason G, Kulkarni GS, Nathens AB, Nam RK, Satkunasivam R.

Can Urol Assoc J. 2017 Nov;11(11):E414-E420. doi: 10.5489/cuaj.4478.

24.

Comparison of postoperative outcomes among patients treated by male and female surgeons: a population based matched cohort study.

Wallis CJ, Ravi B, Coburn N, Nam RK, Detsky AS, Satkunasivam R.

BMJ. 2017 Oct 10;359:j4366. doi: 10.1136/bmj.j4366.

25.

Association Between Use of Antithrombotic Medication and Hematuria-Related Complications.

Wallis CJD, Juvet T, Lee Y, Matta R, Herschorn S, Kodama R, Kulkarni GS, Satkunasivam R, Geerts W, McLeod A, Narod SA, Nam RK.

JAMA. 2017 Oct 3;318(13):1260-1271. doi: 10.1001/jama.2017.13890.

26.

Radical cystectomy in patients with disseminated disease: An assessment of perioperative outcomes using the National Surgical Quality Improvement Program database.

Wallis C, Khana S, Hajiha M, Nam RK, Satkunasivam R.

Can Urol Assoc J. 2017 Aug;11(8):244-248. doi: 10.5489/cuaj.4208.

27.

Role of mpMRI of the prostate in screening for prostate cancer.

Wallis CJD, Haider MA, Nam RK.

Transl Androl Urol. 2017 Jun;6(3):464-471. doi: 10.21037/tau.2017.04.31. Review.

28.

Survival and Complications Following Surgery and Radiation for Localized Prostate Cancer: An International Collaborative Review.

Wallis CJD, Glaser A, Hu JC, Huland H, Lawrentschuk N, Moon D, Murphy DG, Nguyen PL, Resnick MJ, Nam RK.

Eur Urol. 2018 Jan;73(1):11-20. doi: 10.1016/j.eururo.2017.05.055. Epub 2017 Jun 11. Review.

PMID:
28610779
29.

Estimating the effect of immortal-time bias in urological research: a case example of testosterone-replacement therapy.

Wallis CJD, Saskin R, Narod SA, Law C, Kulkarni GS, Seth A, Nam RK.

BJU Int. 2017 Oct;120(4):584-590. doi: 10.1111/bju.13918. Epub 2017 Jun 18. Review.

30.

Adjuvant Versus Salvage Radiotherapy for Patients With Adverse Pathological Findings Following Radical Prostatectomy: A Decision Analysis.

Wallis CJD, Morton G, Jerath A, Satkunasviam R, Szumacher E, Herschorn S, Kodama RT, Kulkarni GS, Naimark D, Nam RK.

MDM Policy Pract. 2017 May 19;2(1):2381468317709476. doi: 10.1177/2381468317709476. eCollection 2017 Jan-Jun.

31.

Effect of statins as a secondary chemopreventive agent among individuals with non-muscle-invasive bladder cancer: A population-based analysis.

Richard PO, Ahmad AE, Bashir S, Hamilton RJ, Nam RK, Leao R, Jeldres C, Kulkarni GS.

Urol Oncol. 2017 Jun;35(6):342-348. doi: 10.1016/j.urolonc.2016.12.009. Epub 2017 Feb 9.

PMID:
28190747
32.

Perioperative outcomes following radical prostatectomy for patients with disseminated cancer: An analysis of the National Surgical Quality Improvement Program database.

Satkunasivam R, Wallis CJ, Byrne J, Hoffman A, Cheung DC, Kulkarni GS, Nathens AB, Nam RK.

Can Urol Assoc J. 2016 Nov-Dec;10(11-12):423-429. doi: 10.5489/cuaj.3939.

33.

Tracking the dynamics of circulating tumour cell phenotypes using nanoparticle-mediated magnetic ranking.

Poudineh M, Aldridge PM, Ahmed S, Green BJ, Kermanshah L, Nguyen V, Tu C, Mohamadi RM, Nam RK, Hansen A, Sridhar SS, Finelli A, Fleshner NE, Joshua AM, Sargent EH, Kelley SO.

Nat Nanotechnol. 2017 Mar;12(3):274-281. doi: 10.1038/nnano.2016.239. Epub 2016 Nov 21.

PMID:
27870841
34.

Postoperative Radiotherapy in Locally Advanced Prostate Cancer: A Question of Who and When.

Wallis CJD, Satkunasivam R, Nam RK.

Eur Urol. 2017 Jun;71(6):894-895. doi: 10.1016/j.eururo.2016.11.010. Epub 2016 Nov 17. No abstract available.

PMID:
27866843
35.

Contemporary evidence for robot-assisted radical cystectomy for treating bladder cancer.

Satkunasivam R, Wallis CJ, Nam RK, Desai M, Gill IS.

Nat Rev Urol. 2016 Sep;13(9):533-9. doi: 10.1038/nrurol.2016.139. Epub 2016 Aug 9. Review.

PMID:
27502548
36.

Cardiovascular and Skeletal-related Events Following Localized Prostate Cancer Treatment: Role of Surgery, Radiotherapy, and Androgen Deprivation.

Wallis CJ, Mahar AL, Satkunasivam R, Herschorn S, Kodama RT, Lee Y, Kulkarni GS, Narod SA, Nam RK.

Urology. 2016 Nov;97:145-152. doi: 10.1016/j.urology.2016.08.002. Epub 2016 Aug 5.

PMID:
27502032
37.

Occurrence of and Risk Factors for Urological Intervention During Benign Hysterectomy: Analysis of the National Surgical Quality Improvement Program Database.

Wallis CJ, Cheung DC, Garbens A, Kroft J, Carr L, Nathens AB, Po L, Nam RK, Liu G, Gien L, Satkunasivam R.

Urology. 2016 Nov;97:66-72. doi: 10.1016/j.urology.2016.06.037. Epub 2016 Jun 29.

PMID:
27374733
38.

Morbidity and Mortality of Radical Nephrectomy for Patients With Disseminated Cancer: An Analysis of the National Surgical Quality Improvement Program Database.

Wallis CJ, Bjarnason G, Byrne J, Cheung DC, Hoffman A, Kulkarni GS, Nathens AB, Nam RK, Satkunasivam R.

Urology. 2016 Sep;95:95-102. doi: 10.1016/j.urology.2016.04.055. Epub 2016 Jun 9.

PMID:
27292566
39.

Hospitalizations to Manage Complications of Modern Prostate Cancer Treatment in Older Men.

Wallis CJD, Mahar AL, Cheung P, Herschorn S, Satkunasivam R, Al-Matar A, Kulkarni GS, Lee Y, Kodama RT, Narod SA, Nam RK.

Urology. 2016 Oct;96:142-147. doi: 10.1016/j.urology.2016.05.054. Epub 2016 Jun 8.

PMID:
27289026
40.

Survival and cardiovascular events in men treated with testosterone replacement therapy: an intention-to-treat observational cohort study.

Wallis CJ, Lo K, Lee Y, Krakowsky Y, Garbens A, Satkunasivam R, Herschorn S, Kodama RT, Cheung P, Narod SA, Nam RK.

Lancet Diabetes Endocrinol. 2016 Jun;4(6):498-506. doi: 10.1016/S2213-8587(16)00112-1. Epub 2016 May 7.

PMID:
27165609
41.

MiR-301a regulates E-cadherin expression and is predictive of prostate cancer recurrence.

Nam RK, Benatar T, Wallis CJ, Amemiya Y, Yang W, Garbens A, Naeim M, Sherman C, Sugar L, Seth A.

Prostate. 2016 Jul;76(10):869-84. doi: 10.1002/pros.23177. Epub 2016 Mar 15.

PMID:
26990571
42.

Effect of radical prostatectomy surgeon volume on complication rates from a large population-based cohort.

Almatar A, Wallis CJ, Herschorn S, Saskin R, Kulkarni GS, Kodama RT, Nam RK.

Can Urol Assoc J. 2016 Jan-Feb;10(1-2):45-9. doi: 10.5489/cuaj.3214.

43.

Second malignancies after radiotherapy for prostate cancer: systematic review and meta-analysis.

Wallis CJ, Mahar AL, Choo R, Herschorn S, Kodama RT, Shah PS, Danjoux C, Narod SA, Nam RK.

BMJ. 2016 Mar 2;352:i851. doi: 10.1136/bmj.i851. Review.

45.

A Pilot Study to Evaluate the Role of Magnetic Resonance Imaging for Prostate Cancer Screening in the General Population.

Nam RK, Wallis CJ, Stojcic-Bendavid J, Milot L, Sherman C, Sugar L, Haider MA.

J Urol. 2016 Aug;196(2):361-6. doi: 10.1016/j.juro.2016.01.114. Epub 2016 Feb 13.

PMID:
26880413
46.

Interrogating Circulating Microsomes and Exosomes Using Metal Nanoparticles.

Zhou YG, Mohamadi RM, Poudineh M, Kermanshah L, Ahmed S, Safaei TS, Stojcic J, Nam RK, Sargent EH, Kelley SO.

Small. 2016 Feb 10;12(6):727-32. doi: 10.1002/smll.201502365. Epub 2015 Dec 28.

PMID:
26707703
47.

Surgery Versus Radiotherapy for Clinically-localized Prostate Cancer: A Systematic Review and Meta-analysis.

Wallis CJD, Saskin R, Choo R, Herschorn S, Kodama RT, Satkunasivam R, Shah PS, Danjoux C, Nam RK.

Eur Urol. 2016 Jul;70(1):21-30. doi: 10.1016/j.eururo.2015.11.010. Epub 2015 Dec 15. Review.

48.

MiR-182 Is Associated with Growth, Migration and Invasion in Prostate Cancer via Suppression of FOXO1.

Wallis CJ, Gordanpour A, Bendavid JS, Sugar L, Nam RK, Seth A.

J Cancer. 2015 Oct 25;6(12):1295-305. doi: 10.7150/jca.13176. eCollection 2015.

49.

New Rates of Interventions to Manage Complications of Modern Prostate Cancer Treatment in Older Men.

Wallis CJ, Mahar A, Cheung P, Herschorn S, Klotz LH, Al-Matar A, Kulkarni GS, Lee Y, Kodama RT, Narod SA, Nam RK.

Eur Urol. 2016 May;69(5):933-41. doi: 10.1016/j.eururo.2015.10.043. Epub 2015 Nov 11.

PMID:
26572707
50.

Identification and Validation of a Five MicroRNA Signature Predictive of Prostate Cancer Recurrence and Metastasis: A Cohort Study.

Nam RK, Amemiya Y, Benatar T, Wallis CJ, Stojcic-Bendavid J, Bacopulos S, Sherman C, Sugar L, Naeim M, Yang W, Zhang A, Klotz LH, Narod SA, Seth A.

J Cancer. 2015 Sep 15;6(11):1160-71. doi: 10.7150/jca.13397. eCollection 2015.

Supplemental Content

Support Center